CRBU
Caribou Biosciences·NASDAQ
--
--(--)
--
--(--)
5.52 / 10
Netural
Analyst coverage is limited but bullish: Clear Street initiated at Buy with a 100% historical win rate. Fund-flow analysis shows a 7.57/10 score with overall inflow ratios below 0.5, indicating moderate buying pressure without strong trend confirmation. The combination of positive analyst sentiment and decent fund inflows offsets some technical weaknesses, yet neither factor alone is decisive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionClear Street
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for CRBU?
- CRBU holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.52/10 (Netural).
